Juvenile Dermatomyositis Latest Advances

Efficacy and Safety of Baricitinib in Refractory Juvenile Dermatomyositis: A Retrospective Study.

Journal: American journal of therapeutics

Published: August 28, 2026

A case of juvenile dermatomyositis complicated by T-lymphoblastic lymphoma

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: August 17, 2026

Liquefied Calcinosis Cutis Mimicking an Abscess in a Clinically Inactive Anti-MDA5 Antibody Positive Juvenile Dermatomyositis.

Journal: International journal of rheumatic diseases

Published: June 08, 2026

Baricitinib Therapy for Refractory Juvenile Dermatomyositis Complicated by Extensive Calcinosis: A Case Report.

Journal: Pediatrics international : official journal of the Japan Pediatric Society

Published: June 03, 2026

Single nucleus RNA sequencing of juvenile dermatomyositis skeletal muscle identifies altered angiogenic signaling.

Journal: bioRxiv : the preprint server for biology

Published: May 18, 2026

Juvenile dermatomyositis in Latvia: clinical, radiologic, laboratory, and therapeutic findings from 2010 to 2025.

Journal: Frontiers in pediatrics

Published: May 13, 2026

Childhood systemic lupus erythematosus with lupus myositis: A report of 6 cases.

Journal: Lupus

Published: May 05, 2026

Vedolizumab as a rescue therapy for severe gastrointestinal involvement in anti-NXP2 positive juvenile dermatomyositis.

Journal: Rheumatology (Oxford, England)

Published: April 20, 2026

NMJ-associated transcriptomic remodeling correlates with disease severity in juvenile dermatomyositis.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: April 16, 2026

Nailfold capillary phenotypes distinguish juvenile myositis subtypes and associate with disease activity.

Journal: Clinical and translational medicine

Published: April 02, 2026

Calcinosis Cutis as the Leading Manifestation of Juvenile Dermatomyositis: A Case Report.

Journal: Case reports in dermatology

Published: March 18, 2026

Systematic Literature Review Informing Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-Endorsed Recommendations for the Treat-to-Target Strategy in Juvenile Dermatomyositis.

Journal: The Journal of rheumatology

Published: March 15, 2026

Juvenile Dermatomyositis Latest Advances

Find the Latest Research About Juvenile Dermatomyositis

Efficacy and Safety of Baricitinib in Refractory Juvenile Dermatomyositis: A Retrospective Study.

Efficacy and Safety of Baricitinib in Refractory Juvenile Dermatomyositis: A Retrospective Study.

A case of juvenile dermatomyositis complicated by T-lymphoblastic lymphoma

A case of juvenile dermatomyositis complicated by T-lymphoblastic lymphoma

Liquefied Calcinosis Cutis Mimicking an Abscess in a Clinically Inactive Anti-MDA5 Antibody Positive Juvenile Dermatomyositis.

Liquefied Calcinosis Cutis Mimicking an Abscess in a Clinically Inactive Anti-MDA5 Antibody Positive Juvenile Dermatomyositis.

Baricitinib Therapy for Refractory Juvenile Dermatomyositis Complicated by Extensive Calcinosis: A Case Report.

Baricitinib Therapy for Refractory Juvenile Dermatomyositis Complicated by Extensive Calcinosis: A Case Report.

Single nucleus RNA sequencing of juvenile dermatomyositis skeletal muscle identifies altered angiogenic signaling.

Single nucleus RNA sequencing of juvenile dermatomyositis skeletal muscle identifies altered angiogenic signaling.

Juvenile dermatomyositis in Latvia: clinical, radiologic, laboratory, and therapeutic findings from 2010 to 2025.

Juvenile dermatomyositis in Latvia: clinical, radiologic, laboratory, and therapeutic findings from 2010 to 2025.

Childhood systemic lupus erythematosus with lupus myositis: A report of 6 cases.

Childhood systemic lupus erythematosus with lupus myositis: A report of 6 cases.

Vedolizumab as a rescue therapy for severe gastrointestinal involvement in anti-NXP2 positive juvenile dermatomyositis.

Vedolizumab as a rescue therapy for severe gastrointestinal involvement in anti-NXP2 positive juvenile dermatomyositis.

NMJ-associated transcriptomic remodeling correlates with disease severity in juvenile dermatomyositis.

NMJ-associated transcriptomic remodeling correlates with disease severity in juvenile dermatomyositis.

Nailfold capillary phenotypes distinguish juvenile myositis subtypes and associate with disease activity.

Nailfold capillary phenotypes distinguish juvenile myositis subtypes and associate with disease activity.

Calcinosis Cutis as the Leading Manifestation of Juvenile Dermatomyositis: A Case Report.

Calcinosis Cutis as the Leading Manifestation of Juvenile Dermatomyositis: A Case Report.

Systematic Literature Review Informing Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-Endorsed Recommendations for the Treat-to-Target Strategy in Juvenile Dermatomyositis.

Systematic Literature Review Informing Paediatric Rheumatology European Society/Childhood Arthritis and Rheumatology Research Alliance-Endorsed Recommendations for the Treat-to-Target Strategy in Juvenile Dermatomyositis.